[Disclosure] Hanamicron (067310) First-Stage Issue Price for Rights Offering Set at KRW 18,520

Source Facts: Financial Supervisory Service (DART) / 2024-06-18

Disclosure Type: Determination of First-Stage Issue Price for Rights Offering

💡 3-Second Summary Hanamicron has set the first-stage issue price for its rights offering at KRW 18,520 per share, with the final price to be determined on July 24 and announced on July 25.

📊 1. [Key Disclosure Details and Figures]

• Shares to be Issued: 5,000,000 shares
• 1st Stage Issue Price: KRW 18,520 per share
• Par Value: KRW 500 per share
• Calculation Date: June 17, 2024
• Future Schedule: Final price determination (July 24, 2024) → Final announcement (July 25, 2024)

📈 2. [Expert Insight: Impact on Stock Price] Setting the first-stage issue price provides a benchmark for shareholders considering participation. This figure will be compared with the second-stage price to determine the final issue price. The spread between this offer price and current market prices will directly influence shareholder participation, potential unsubscribed shares, and the success of the general public offering. Investors should keep a close watch on market trends leading up to the final price setting in late July.

📝 Editor’s Comment (by K-STOCK Editor)

With the first-stage price now out, the countdown to the final price begins. Since this figure reflects the market trend as of the calculation date, I advise investors to evaluate the current market valuation against this offer price to refine their subscription strategies. A lower final price could boost subscription appeal, but keep an eye on how the total capital-raising targets might be adjusted accordingly.

📢 Disclaimer and Source Information Source: This content is structured and rewritten based on the official data submitted to the Financial Supervisory Service (DART).

Investment Risk Warning: This content is provided for information and linguistic reference purposes only. It does not constitute financial advice or a recommendation to buy or sell any specific stock under any circumstances. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance or copyright inquiries, please contact ksb220805@gmail.com.